ORIC Pharmaceuticals Inc
ORIC
Market Cap$403.05M
Close$
$0.81
84.8% downside
Current Fair Value
84.8% downsideOvervalued by 84.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $403.05 Million |
|---|---|
| Enterprise Value | $346.83 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.83 |
| Beta | 1.37 |
| Outstanding Shares | 70,652,013 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.13 |
|---|---|
| PEG | -8.78 |
| Price to Sales | - |
| Price to Book Ratio | 1.77 |
| Enterprise Value to Revenue | 225.51 |
| Enterprise Value to EBIT | -2.57 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ORIC Pharmaceuticals Inc
CEO: Jacob Chacko